Product image of Factane (Human Coagulation Factor Viii) supplied by GNH India

Factane

Active Ingredient:
Human Coagulation Factor Viii
Origin:
EU

Factane (Human Coagulation Factor Viii)

Factane is a human coagulation factor VIII used to manage bleeding disorders. This intravenous medication supports clotting and is manufactured by Lfb Biomedicaments in the EU.

Manufacturer / TM Owner

Lfb Biomedicaments

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Factane is primarily used to treat bleeding episodes in individuals with hemophilia A, a condition where the body lacks sufficient factor VIII. It helps to replace the missing clotting factor, reducing bleeding risks. Factane may also be used before surgeries to prevent excessive bleeding. The medication is administered intravenously to ensure rapid absorption and effectiveness.

Side Effects

  • Common effects of Factane may include mild reactions at the injection site, such as redness or swelling. Some users might experience flu-like symptoms, including fever or chills. Severe allergic reactions are rare but require immediate medical attention. Always consult a healthcare provider for personalized advice.

Precautions & Warnings

  • Factane should be handled with care, ensuring proper storage and administration. It is crucial to follow medical guidance for dosage and frequency. Individuals with known allergies to factor VIII or its components should avoid Factane. Regular monitoring may be necessary to assess treatment effectiveness and side effects.

Avoid Interactions

  • Factane may interact with certain medications, including those that affect blood clotting. Always inform your healthcare provider about all medications you are taking. Alcohol and other substances that thin the blood should be avoided. Consult a healthcare professional for personalized advice on managing potential interactions.

Frequently Asked Questions

Factane is used to manage bleeding episodes in individuals with hemophilia A by replacing the missing clotting factor VIII.

Factane is administered intravenously to ensure rapid absorption and effectiveness in managing bleeding disorders.

Common side effects may include mild reactions at the injection site, such as redness or swelling, and flu-like symptoms.

Yes, Factane may be used before surgeries to prevent excessive bleeding in individuals with hemophilia A.

Individuals with known allergies to factor VIII or its components should avoid Factane.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Human Coagulation Factor Viii

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT